Show simple item record

dc.contributor.authorBianchi, María Beatrice
dc.contributor.authorZhang, Chunyang
dc.contributor.authorCatlin, Elise
dc.contributor.authorSandri, Giuseppina
dc.contributor.authorCalderón, Marcelo
dc.contributor.authorLarrañeta, Eneko
dc.contributor.authorDonnelly, Ryan F.
dc.contributor.authorPicchio, Matías L.
dc.contributor.authorParedes, Alejandro J.
dc.date.accessioned2023-01-31T17:53:38Z
dc.date.available2023-01-31T17:53:38Z
dc.date.issued2022-12
dc.identifier.citationMaterials Today Bio 17 : (2022) // Article ID 100471es_ES
dc.identifier.issn2590-0064
dc.identifier.urihttp://hdl.handle.net/10810/59581
dc.description.abstractutectogels (Egels) are an emerging class of soft ionic materials outperforming traditional temperature-intolerant hydrogels and costly ionogels. Due to their excellent elasticity, non-volatile nature, and adhesion properties, Egels are attracting a great deal of interest in the biomedical space. Herein, we report the first example of adhesive Egels loading drug nanocrystals (Egel-NCs) for controlled delivery to mucosal tissues. These soft materials were pre-pared using gelatin, glycerine, a deep eutectic solvent (DES) based on choline hydrochloride and glycerol, and nanocrystallised curcumin, a model drug with potent antimicrobial and anti-inflammatory activities. We first explored the impact of the biopolymer concentration on the viscoelastic and mechanical properties of the net-works. Thanks to the dynamic interactions between gelatin and the DES, the Egel showed excellent stretchability and elasticity (up to asymptotic to 160%), reversible gel-sol phase transition at mild temperature (asymptotic to 150 degrees C), 3D-printing ability, and good adhesion to mucin protein (stickiness asymptotic to 40 kPa). In vitro release profiles demonstrated the ability of the NCs-based Egel to deliver curcumin for up to four weeks and deposit significantly higher drug amounts in excised porcine mucosa compared to the control cohort. All in all, this study opens new prospects in designing soft adhesive materials for long-acting drug delivery and paves the way to explore novel eutectic systems with multiple therapeutic applications.es_ES
dc.description.sponsorshipThis work was financially supported by the Wellcome Trust (UNS40040). M.B.B. received funding from Erasmus+ Traineeships for students abroad. M.L.P. has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement no. 101028881.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/101028881es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectnanocrystalses_ES
dc.subjecteutectogelses_ES
dc.subjectbioadhesiones_ES
dc.subjectdrug deliveryes_ES
dc.subject3D printinges_ES
dc.subjectcurcumines_ES
dc.titleBioadhesive eutectogels supporting drug nanocrystals for long-acting delivery to mucosal tissueses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder© 2022 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)es_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S2590006422002691?via%3Dihubes_ES
dc.identifier.doi10.1016/j.mtbio.2022.100471
dc.contributor.funderEuropean Commission


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2022 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
Except where otherwise noted, this item's license is described as © 2022 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)